Opportunities Preloader

Please Wait.....

Report

Global Insulin Pens Market Report and Forecast 2023-2031

Market Report I 2023-05-06 I 160 Pages I EMR Inc.

Global Insulin Pens Market Report and Forecast 2023-2031

Global Insulin Pens Market Outlook

The global insulin pens market size attained a value of USD 40.7 million in 2022. The market is expected to grow at a CAGR of 3.1% during the forecast period of 20231-2031 to attain a value of USD 52.1 million by 2031.

Insulin Pens Market: Introduction
Insulin pens are devices used to inject insulin, a hormone that regulates the amount of glucose in the blood. They are commonly used in the treatment of diabetes, a condition where the body either does not produce enough insulin (Type 1 diabetes) or cannot effectively use the insulin it produces (Type 2 diabetes).
An insulin pen consists of a cartridge of insulin, a dial to measure the dosage, and a disposable needle. There are two types of insulin pens: reusable pens, where the insulin cartridge is replaced when it's empty, and disposable pens, which are discarded after the insulin is used up.
Insulin pens are used to administer insulin in a simple, convenient, and accurate manner. The user selects the required dose of insulin on the pen, inserts the needle into the skin, and pushes the button at the end of the pen to inject the insulin.
Insulin pens can be used for all types of insulin, including rapid-acting, short-acting, intermediate-acting, and long-acting insulin. The type of insulin used depends on the individual's specific needs and the recommendation of their healthcare provider.
The key benefits of insulin pens include the following:
- Ease of Use: Insulin pens are straightforward to use, even for people with limited dexterity or vision. The dose can be dialled easily, and the push-button injection requires less strength than a traditional syringe.
- Portability: Insulin pens are compact and easy to carry, which makes them convenient for people who are often on the go.
- Accuracy: Insulin pens offer more accurate dosing than traditional insulin syringes, particularly for low doses.
- Less Painful: The needles used with insulin pens are often thinner and shorter than those used with syringes, which can make injections less painful.
- Discreet: Using an insulin pen can be a more discreet way to administer insulin, which can be a significant advantage for people who feel self-conscious about injecting insulin in public.
- Less Wastage: Insulin pens can reduce wastage of insulin as compared to vials and syringes.
Despite these benefits, it is important to note that insulin pens are more expensive than traditional vials and syringes. The decision to use an insulin pen or a traditional syringe depends on an individual's specific needs, lifestyle, and financial considerations. As always, this decision should be made in consultation with a healthcare provider.
Insulin Pens Market Segmentations
The market can be categorised into product type, disease type, distribution channel, and major regions.
Market Breakup by Product Type
- Disposable Insulin Pen
- Reusable Insulin Pen
Market Breakup by Disease Type
- Type I Diabetes
- Type II Diabetes
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Diabetes Clinics
- Others
Insulin Pens Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others


Insulin Pens Market Scenario
The global market for insulin pens has been witnessing robust growth, driven primarily by the rising prevalence of diabetes, technological advancements in insulin delivery devices, and the growing preference for pens over syringes and vials due to their convenience and ease of use. As of my last knowledge update in September 2021, the insulin pens market was expected to continue growing well into the future.
A key driving force behind the growth of the insulin pens market is the increasing incidence of diabetes worldwide. Factors such as unhealthy dietary habits, sedentary lifestyles, and obesity are contributing to this rise. As a result, the demand for effective and convenient insulin delivery systems like insulin pens is also increasing.
Technological advancements are another major factor contributing to the growth of the insulin pens market. Modern insulin pens offer several features that make them more user-friendly, such as memory functions that record the time and amount of the last dose, adjustable dose settings, and minimal injection force required. These features enhance patient compliance and make insulin therapy more manageable for individuals with diabetes.
In terms of market segmentation, reusable insulin pens hold a significant share of the market. However, the disposable pens segment is anticipated to grow at a faster rate due to their convenience and the reduced risk of cross-contamination.
Geographically, North America dominates the global insulin pens market due to the high prevalence of diabetes, advanced healthcare infrastructure, and higher adoption of technologically advanced insulin delivery devices. However, the Asia Pacific region is expected to witness significant growth due to rising diabetes prevalence, increasing healthcare expenditure, and growing awareness about diabetes management.
However, the market also faces challenges. The high cost of insulin pens compared to traditional insulin delivery methods can be a barrier for many patients, particularly in lower-income regions where healthcare resources may be limited.
In conclusion, the global insulin pens market is set for substantial growth, propelled by the rising prevalence of diabetes and technological advancements in insulin delivery devices. However, addressing the cost-related barriers will be crucial to ensure more widespread adoption of this beneficial technology.

Key Players in the Global Insulin Pens Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

- Nikkiso Co., Ltd.
- Asahi Kasei Medical Co. Ltd
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Terumo Bct, Inc
- Haemonetics Corporation
- Mallinckrodt
- Kaneka Corporation
- Kawasumi Laboratories, Inc.
- Miltenyi Biotec
- Infomed
- Toray Medical Co., Ltd.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Insulin Pens Market Overview
3.1 Global Insulin Pens Market Historical Value (2016-2022)
3.2 Global Insulin Pens Market Forecast Value (2023-2031)
4 Global Insulin Pens Market Landscape
4.1 Global Insulin Pens Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Insulin Pens Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Disease Type
4.2.3 Analysis by Distribution Channel
5 Global Insulin Pens Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Insulin Pens Market Segmentation
6.1 Global Insulin Pens Market by Product Type
6.1.1 Market Overview
6.1.2 Disposable Insulin Pen
6.1.3 Reusable Insulin Pen
6.2 Global Insulin Pens Market by Disease Type
6.2.1 Market Overview
6.2.2 Type I Diabetes
6.2.3 Type II Diabetes
6.3 Global Insulin Pens Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacy
6.3.3 Retail Pharmacy
6.3.4 Online Pharmacy
6.3.5 Diabetes Clinics
6.3.6 Others
6.4 Global Insulin Pens Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Insulin Pens Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Insulin Pens Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Insulin Pens Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Insulin Pens Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Insulin Pens Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Nikkiso Co., Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Asahi Kasei Medical Co. Ltd
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 B. Braun Melsungen AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Fresenius SE & Co. KGaA
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Terumo Bct, Inc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Haemonetics Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Mallinckrodt
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Kaneka Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Kawasumi Laboratories, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Miltenyi Biotec
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Infomed
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Toray Medical Co., Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Insulin Pens Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE